Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2000 Jul 29;321(7256):252-3.
doi: 10.1136/bmj.321.7256.252.

Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials

A J Krentz, C J Bailey, A Melander
Editorial

Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials

A J Krentz et al. BMJ. .
No abstract available

PubMed Disclaimer

Comment in

References

    1. Krentz AJ. Insulin resistance. BMJ. 1996;313:1385–1389. - PMC - PubMed
    1. Ericksson J, Farnssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, et al. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med. 1989;321:337–341. - PubMed
    1. Reaven GM. Insulin resistance in human disease. Diabetes. 1988;37:1595–1607. - PubMed
    1. Day C. Thiazolidinediones: a new class of antidiabetic drugs. Diabet Med. 1999;16:179–192. - PubMed
    1. Schoonjans K, Auwerx J. Thiazolidinediones: an update. Lancet. 2000;355:1008–1010. - PubMed

Publication types